Hamilton Thorne (CVE:HTL) Stock Price Up 4.3% – Still a Buy?

Shares of Hamilton Thorne Ltd. (CVE:HTL) rose 4.3% on Wednesday . The stock traded as high as C$1.45 and last traded at C$1.45. Approximately 25,700 shares changed hands during mid-day trading, a decline of 27% from the average daily volume of 35,118 shares. The stock had previously closed at C$1.39.

Hamilton Thorne Stock Performance

The company has a quick ratio of 2.25, a current ratio of 2.63 and a debt-to-equity ratio of 33.94. The stock has a market capitalization of C$212.89 million, a P/E ratio of 48.33 and a beta of 0.54. The business has a fifty day moving average price of C$1.45 and a 200-day moving average price of C$1.45.

Insider Buying and Selling at Hamilton Thorne

In other news, insider AWM Investment Company, Inc. acquired 783,000 shares of the business’s stock in a transaction that occurred on Thursday, October 10th. The stock was bought at an average price of C$1.56 per share, with a total value of C$1,221,010.20. Company insiders own 29.41% of the company’s stock.

About Hamilton Thorne

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets.